Chinese Journal of New Drugs and Clinical Remedies
|
2024, 43(4): 318-320
• Pharmacovigilance •
One case of severe immune mediated hepatotoxicity in advanced non-small cell lung cancer patients treated with sintilimab
Full
Feng LIU
1, Ran XIE
1, Hong-ying FANG
1, Yu-guo XU
1, Hai-xia ZHANG
1, Mei HU
1, Xiang-hua QUAN
2
Affiliations
- 1.Department of Pharmacy, Zibo Hospital of Integrated Traditional Chinese and Western Medicine, Zibo SHANDONG 255026, China
- 2.Department of Pharmacy, the Affiliated Hospital of Qingdao University, Qingdao SHANDONG 266000,China
Published: 2024-04-25
doi: 10.14109/j.cnki.xyylc.2024.04.14
Outline
sintilimab
/
glucocorticoids
/
immunotherapy
/
drug-induced liver injury
/
adverse drug reactions
Feng LIU, Ran XIE, Hong-ying FANG, Yu-guo XU, Hai-xia ZHANG, Mei HU, Xiang-hua QUAN.
One case of severe immune mediated hepatotoxicity in advanced non-small cell lung cancer patients treated with sintilimab[J].
Chinese Journal of New Drugs and Clinical Remedies,
2024
, 43
(4)
: 318
-320
.
DOI: 10.14109/j.cnki.xyylc.2024.04.14
Year 2024 volume 43 Issue 4
PDF
114
55
Cite this Article
BibTeX
Article Info
doi: 10.14109/j.cnki.xyylc.2024.04.14
- Receive Date:2022-07-05
- Online Date:2026-03-13
- Published:2024-04-25